NO963818L - Forhöyet utskillelse av polypeptider - Google Patents

Forhöyet utskillelse av polypeptider

Info

Publication number
NO963818L
NO963818L NO963818A NO963818A NO963818L NO 963818 L NO963818 L NO 963818L NO 963818 A NO963818 A NO 963818A NO 963818 A NO963818 A NO 963818A NO 963818 L NO963818 L NO 963818L
Authority
NO
Norway
Prior art keywords
polypeptides
increased secretion
sequence
ngf polypeptides
enhancing
Prior art date
Application number
NO963818A
Other languages
English (en)
Other versions
NO963818D0 (no
Inventor
Shi-Yuan Meng
Charles F Morris
Larry B Tsai
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of NO963818D0 publication Critical patent/NO963818D0/no
Publication of NO963818L publication Critical patent/NO963818L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Signalpeptidsekvens og nuklein- syrer som koder for denne sekvens, som er anvendbar for å forhøye utskillel- seseffektiviteten av NGF-polypeptider. Videre tilveiebringes en fremgangsmåte for fremstilling av Met-løse NGF-poly-peptider.
NO963818A 1994-03-18 1996-09-12 Forhöyet utskillelse av polypeptider NO963818L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/215,138 US5470719A (en) 1994-03-18 1994-03-18 Modified OmpA signal sequence for enhanced secretion of polypeptides
PCT/US1995/003175 WO1995025743A1 (en) 1994-03-18 1995-03-16 Enhanced secretion of polypeptides

Publications (2)

Publication Number Publication Date
NO963818D0 NO963818D0 (no) 1996-09-12
NO963818L true NO963818L (no) 1996-11-15

Family

ID=22801818

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963818A NO963818L (no) 1994-03-18 1996-09-12 Forhöyet utskillelse av polypeptider

Country Status (15)

Country Link
US (2) US5470719A (no)
EP (1) EP0750634A1 (no)
JP (1) JPH09510611A (no)
AU (1) AU689569B2 (no)
CA (1) CA2185343A1 (no)
CZ (1) CZ284204B6 (no)
FI (1) FI963655L (no)
HU (1) HUT76674A (no)
IL (1) IL112982A0 (no)
MX (1) MX9604047A (no)
NO (1) NO963818L (no)
NZ (1) NZ283214A (no)
SK (1) SK116896A3 (no)
WO (1) WO1995025743A1 (no)
ZA (1) ZA952218B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747662A (en) * 1995-03-01 1998-05-05 Genentech, Inc. Methods and compositions for secretion of heterologous polypeptides
US5888796A (en) * 1996-01-31 1999-03-30 St. Louis University Clone of a nucleotide sequence encoding a protein having two functions
US20020065394A1 (en) * 1998-03-18 2002-05-30 Kenneth Jacobs Secreted proteins and polynucleotides encoding them
KR100360594B1 (ko) * 2000-01-19 2002-11-13 한미약품공업 주식회사 인간 인터페론 알파의 발현 분비벡터 및 이를 이용한인터페론 알파의 생산 방법
AU2001275267A1 (en) 2000-06-05 2001-12-17 Corixa Corporation Leader peptides for enhancing secretion of recombinant protein from a host cell
US20060239966A1 (en) * 2003-10-20 2006-10-26 Tornoee Jens In vivo gene therapy of parkinson's disease
WO2007137300A2 (en) 2006-05-23 2007-11-29 Bellicum Pharmaceuticals, Inc. Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
US8097422B2 (en) 2007-06-20 2012-01-17 Salk Institute For Biological Studies Kir channel modulators
US20090280103A1 (en) * 2008-04-04 2009-11-12 Martin Flueck Regulation of muscle repair
WO2010033229A2 (en) * 2008-09-22 2010-03-25 Calmune Corporation Methods and vectors for display of molecules and displayed molecules and collections
CA2765849A1 (en) 2009-07-02 2011-01-06 Verdezyne, Inc. Biological methods for preparing adipic acid
EP2451960A2 (en) 2009-07-09 2012-05-16 Verdezyne, Inc. Engineered microorganisms with enhanced fermentation activity
US8889394B2 (en) * 2009-09-07 2014-11-18 Empire Technology Development Llc Multiple domain proteins
US8343752B2 (en) 2011-05-03 2013-01-01 Verdezyne, Inc. Biological methods for preparing adipic acid
US8728798B2 (en) 2011-05-03 2014-05-20 Verdezyne, Inc. Biological methods for preparing adipic acid
MY184871A (en) 2011-07-06 2021-04-28 Radici Chimica S P A Biological methods for preparing a fatty dicarboxylic acid
MY175858A (en) 2012-12-19 2020-07-14 Corvay Bioproducts Gmbh Biological methods for preparing a fatty dicarboxylic acid
CN105121624A (zh) 2012-12-19 2015-12-02 沃德金有限公司 制备脂肪二羧酸的生物学方法
TWI638047B (zh) 2014-04-09 2018-10-11 史基普研究協會 藉由核酸三磷酸酯轉運子將非天然或經修飾的核苷三磷酸酯輸入至細胞中
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
WO2016154046A2 (en) 2015-03-20 2016-09-29 Verdezyne, Inc. Biological methods for preparing 3-hydroxypropionic acid
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
SG11202000167SA (en) 2017-07-11 2020-02-27 Synthorx Inc Incorporation of unnatural nucleotides and methods thereof
CA3069697A1 (en) 2017-07-13 2019-01-17 Radici Chimica S.P.A. Biological methods for modifying cellular carbon flux
KR20250145137A (ko) 2017-08-03 2025-10-13 신톡스, 인크. 자가면역 질환의 치료를 위한 사이토카인 접합체
CN108610398B (zh) * 2018-01-15 2020-08-11 武汉海特生物制药股份有限公司 一段功能序列及在分泌蛋白表达中的应用
WO2020060948A1 (en) 2018-09-17 2020-03-26 Levadura Biotechnology, Inc. Production of cannabinoids in yeast using a fatty acid feedstock
US20200246467A1 (en) 2019-02-06 2020-08-06 Synthorx, Inc. Il-2 conjugates and methods of use thereof
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
US12537071B1 (en) 2020-07-22 2026-01-27 David Gordon Bermudes Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338397A (en) * 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
US4757013A (en) * 1983-07-25 1988-07-12 The Research Foundation Of State University Of New York Cloning vehicles for polypeptide expression in microbial hosts
US5235043A (en) * 1990-04-06 1993-08-10 Synergen, Inc. Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins
EP0550665B1 (en) * 1990-09-25 1996-07-31 Genentech, Inc. Novel neurothrophic factor
WO1993008300A1 (en) * 1991-10-18 1993-04-29 The University Of Calgary Expression-secretion vectors for the production of biologically active fv fragments
AU4535993A (en) * 1992-06-12 1994-01-04 Regeneron Pharmaceuticals, Inc. Therapeutic and diagnostic methods based on neurotrophin-4 expression
US5474914A (en) * 1992-07-29 1995-12-12 Chiron Corporation Method of producing secreted CMV glycoprotein H

Also Published As

Publication number Publication date
HU9602548D0 (en) 1996-11-28
JPH09510611A (ja) 1997-10-28
CZ264496A3 (en) 1997-05-14
NO963818D0 (no) 1996-09-12
SK116896A3 (en) 1997-08-06
AU689569B2 (en) 1998-04-02
FI963655A7 (fi) 1996-11-15
HUT76674A (en) 1997-10-28
FI963655A0 (fi) 1996-09-16
CZ284204B6 (cs) 1998-09-16
EP0750634A1 (en) 1997-01-02
WO1995025743A1 (en) 1995-09-28
FI963655L (fi) 1996-11-15
US5470719A (en) 1995-11-28
ZA952218B (en) 1995-12-12
CA2185343A1 (en) 1995-09-28
IL112982A0 (en) 1995-06-29
NZ283214A (en) 1998-03-25
AU2119895A (en) 1995-10-09
US5608036A (en) 1997-03-04
MX9604047A (es) 1997-09-30

Similar Documents

Publication Publication Date Title
AU2656695A (en) Purified scytalidium laccases and nucleic acids encoding same
EP1591529A3 (en) Human CLTA-8 and uses of CTLA-8-related proteins
MX9604047A (es) Secrecion aumentada de polipeptidos.
AU2656595A (en) Purified myceliophthora laccases and nucleic acids encoding same
AU2827895A (en) Purified polyporus laccases and nucleic acids encoding same
DE68924654D1 (de) Spezifische Protease.
EP0182372A3 (en) New factor viii coagulant polypeptides
EP0723555A4 (en) CHEMICAL PROTEINS WITH BLOCK SUPPLEMENT ACTIVATION
IL212140A0 (en) Antibodies against acpl polypeptides
NO962188L (no) Nye apoptose-modulerende proteiner, DNA som koder for proteinene og fremgangsmåter for anvendelse derav
ES2075155T3 (es) Separacion enzimatica de una secuencia de una proteina con amino terminal.
DE3789413D1 (de) Lymphokin-ähnliche Peptide.
NO970740L (no) Glutamat reseptor
AU4301589A (en) Soy protein isolation process
AU580348B2 (en) A process for the cleavage of peptides and proteins at the methionyl bond
IE902388L (en) Vasoactive intestinal peptide analogs.
AU570572B2 (en) 4,5-dihydro-4-oxo-2-((2-trans-phenylcyclopropyl) amino)-3- furancarboxylic acid derivatives
DK0635025T3 (da) Fremgangsmåde til fremstilling af modificerede proteiner
AU3752185A (en) Determination of fibrin using fibrin-specific antibodies
AU5708086A (en) Improved protein hydrolysate
DK0816377T3 (da) Peptider, som binder sig til prothrombin og thrombin
FI943218A7 (fi) Kaseinomakropeptidin peptidit, mainittujen peptidien vasta-aineet ja k äytöt
GR3006045T3 (no)
NZ304789A (en) Genes encoding lymphocyte interferon regulatory factory (lsirf) polypeptides that are transcription factors and specific antibodies to them
DK130290A (da) Lymfokiner, dna-sekvenser, som koder for disse lymfokiner og farmaceutiske midler indeholdende disse lymfokiner